|  |  | Univariate/Unadjusted | Multivariate/Adjusteda | ||||
---|---|---|---|---|---|---|---|---|
 | Survivors | Non-survivors | OR | 95 % CI | P value | OR | 95 % CI | P value |
Fever >101.5 F | 480 (49) | 137 (63) | 1.9 | 1.4–2.6 | 0.000 | 0.8 | 0.5–1.3 | 0.35 |
Hyperglycemia, >200 mg/dl | 408 (42) | 143 (66) | 2.9 | 2.1–4.0 | 0.000 | 1.1 | 0.7–1.8 | 0.76 |
Hydrocephalus requiring EVD or VPS | 289 (29) | 142 (66) | 4.7 | 3.5–6.5 | 0.417 | 1.4 | 0.9–2.2 | 0.15 |
Anemia requiring transfusion | 319 (32) | 75 (35) | 1.1 | 0.8–1.6 | 0.000 | 0.7 | 0.45–1.0 | 0.10 |
Global cerebral edema | 205 (21) | 107 (50) | 3.7 | 2.8–5.2 | 0.000 | 1.8 | 1.1–2.9 | 0.02 |
New infarct on CT scan | 233 (24) | 78 (36) | 2.0 | 1.5–2.8 | 0.000 | 0.7 | 0.4–1.1 | 0.09 |
ICP crisis or herniationa | 153 (16) | 106 (49) | 5.7 | 4.0–7.9 | 0.000 | 2.5 | 1.4–3.7 | 0.00 |
Hypotension, <90 mm Hgb | 160 (16) | 122 (57) | 6.7 | 4.9–9.2 | 0.000 | 3.4 | 2.2–5.3 | 0.00 |
Pneumonia | 191 (19) | 67 (31) | 1.9 | 1.4–2.7 | 0.000 | 0.6 | 0.4–1.0 | 0.06 |
Hypernatremia, >150 mEq/l | 151 (15) | 99 (46) | 5.1 | 3.6–7.1 | 0.000 | 2.1 | 1.3–3.4 | 0.00 |
Urinary tract infection | 226 (23) | 13 (6) | 0.2 | 0.1–0.4 | 0.881 | 0.1 | 0.0–0.2 | 0.00 |
Clinical deterioration from vasospasm | 170 (17) | 36 (17) | 0.9 | 0.7–1.4 | 0.000 | 0.9 | 0.6–1.6 | 0.81 |
Pulmonary edema | 137 (14) | 68 (32) | 2.9 | 2.0–4.1 | 0.000 | 1.3 | 0.8–2.0 | 0.33 |
Herniation | 62 (6) | 106 (50) | 15.3 | 10.5–22.1 | 0.052 | 8.3 | 4.9–14.3 | 0.00 |
Hyponatremia, <130 mEq/l | 140 (14) | 20 (9) | 0.6 | 0.4–1.0 | 0.010 | 0.5 | 0.3–0.96 | 0.04 |
Sepsis/Bacteremia | 91 (9) | 32 (15) | 1.8 | 1.1–2.7 | 0.000 | 1.4 | 0.79–2.4 | 0.26 |
Arrhythmia | 71 (7) | 49 (23) | 3.7 | 2.5–5.6 | 0.000 | 1.6 | 0.9–2.8 | 0.09 |
Aneurysm rebleeding | 54 (6) | 64 (30) | 6.9 | 4.6–10.4 | 0.000 | 3.5 | 1.9–5.9 | 0.00 |
Congestive heart failure | 62 (6) | 39 (18) | 3.3 | 2.1–5.1 | 0.001 | 2.2 | 1.3–3.8 | 0.00 |
Seizures | 55 (6) | 25 (12) | 2.3 | 1.4–3.8 | 0.068 | 1.6 | 0.8–3.0 | 0.20 |
Delayed cerebral ischemia | ||||||||
 Symptomatic vasospasm without infarct | 104 (11) | 14 (7) | 0.6 | 0.3–1.0 | 0.095 | 0.5 | 0.3–1.0 | 0.06 |
 Symptomatic vasospasm with infarct | 64 (7) | 21 (10) | 1.5 | 0.9–2.6 | 0.004 | 1.9 | 1.0–3.7 | 0.07 |
 No symptomatic vasospasm with infarct | 23 (2) | 13 (6) | 2.7 | 1.3–5.4 | 0.000 | 2.2 | 0.8–5.8 | 0.13 |
  Non-neurogenic myocardial ischemia | 46 (5) | 43 (20) | 5.1 | 3.3–8.1 | 0.000 | 2.8 | 1.6–5.1 | 0.00 |
  Hepatic injury, AST or ALT >200 mg/dl | 24 (2) | 22 (10) | 4.6 | 2.5–8.4 | 0.000 | 2.5 | 1.2–5.3 | 0.01 |
  GI bleeding requiring transfusion | 19 (2) | 14 (7) | 3.5 | 1.7–7.1 | 0.000 | 1.7 | 0.7–4.3 | 0.27 |